Article

Dicer1 Ablation in the Mouse Epididymis Causes Dedifferentiation of the Epithelium and Imbalance in Sex Steroid Signaling

Department of Physiology, Institute of Biomedicine, University of Turku, Turku, Finland.
PLoS ONE (Impact Factor: 3.23). 06/2012; 7(6):e38457. DOI: 10.1371/journal.pone.0038457
Source: PubMed

ABSTRACT The postnatal development of the epididymis is a complex process that results in a highly differentiated epithelium, divided into several segments. Recent studies indicate a role for RNA interference (RNAi) in the development of the epididymis, however, the actual requirement for RNAi has remained elusive. Here, we present the first evidence of a direct need for RNAi in the differentiation of the epididymal epithelium.
By utilizing the Cre-LoxP system we have generated a conditional knock-out of Dicer1 in the two most proximal segments of the mouse epididymis. Recombination of Dicer1, catalyzed by Defb41(iCre/wt), took place before puberty, starting from 12 days postpartum. Shortly thereafter, downregulation of the expression of two genes specific for the most proximal epididymis (lipocalin 8 and cystatin 8) was observed. Following this, segment development continued until week 5 at which age the epithelium started to regress back to an undifferentiated state. The dedifferentiated epithelium also showed an increase in estrogen receptor 1 expression while the expression of androgen receptor and its target genes; glutathione peroxidase 5, lipocalin 5 and cysteine-rich secretory protein 1 was downregulated, indicating imbalanced sex steroid signaling.
At the time of the final epididymal development, Dicer1 acts as a regulator of signaling pathways essential for maintaining epithelial cell differentiation.

Download full-text

Full-text

Available from: Petra Sipilä, Sep 01, 2015
0 Followers
 · 
113 Views
 · 
55 Downloads
  • Source
    • "The serum T4 levels were measured using the commercial ELISA (Trinity Biotech, NY, USA) according to manufacturer's instructions. Quantitative PCR for Dicer1 was performed as described earlier (Bj€ orkgren et al., 2012). Procedures of animal care and use in this study were approved by the Regierungspr€ asidium Karlsruhe (Karlsruhe, Germany). "
    [Show abstract] [Hide abstract]
    ABSTRACT: We have created a mouse model expressing tamoxifen-inducible Cre recombinase (CreER(T2) ) under the control of the thyroglobulin (Tg) gene promoter to be able to study the role of defined genetic modifications in the regulation of thyroid function. We chose the thyroglobulin promoter, as it is expressed specifically in the thyroid. In order to obtain reliable expression under the control of the Tg promoter we used a P1 artificial chromosome (PAC) containing a large piece of the Tg promoter. A tamoxifen inducible CreER(T2) construct was selected to avoid the possible consequences of the gene deletion for the development of the thyroid gland, and to study the role of gene deletion in the adult thyroid. Transgenic lines (TgCreER(T2) ) carrying this construct were generated and analyzed by crossing the TgCreER(T2) mice with the ROSA26LacZ reporter strain. The activity and specificity of the Cre recombinase was tested by staining for beta-galactosidase activity and by immunohistochemistry using an anti-Cre-antibody. In the TgCreER(T2) xROSA26LacZ reporter line, Cre mediated recombination occurred specifically in the thyrocytes only after tamoxifen administration, and no significant staining was observed in controls. The recombination efficiency was nearly complete since almost all thyrocytes showed X-gal staining. We could also induce the recombination in utero by giving tamoxifen to the pregnant female. In addition, mice expressing TgCreER(T2) had no obvious histological changes, hormonal alterations or different response to growth stimuli as compared to controls. These results demonstrate that the TgCreER(T2) mouse line is a powerful tool to study temporally controlled deletion of floxed genes in the thyroid. © 2013 Wiley Periodicals, Inc.
    genesis 04/2014; 52(4). DOI:10.1002/dvg.22740 · 2.04 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Epididymis plays a crucial role in regulating the development of sperm motility and fertilizing capacity. To study the function of genes in the caput epididymis using Cre/loxP system, we generated Lcn5-Cre transgenic (TG) mice in which the expression of Cre recombinase is driven by the 1.8 kilobase pairs (kb) Lcn5 promoter. Total 11 founder mice carrying the Lcn5-Cre transgene were identified by polymerase chain reaction (PCR) from 38 offspring, and the integration efficiency is 28.9%. But only one of the 11 transgenic mouse lines were revealed with the Cre recombinase expressed specifically in caput epididymis. Furthermore, expression of Cre mRNA was first observed on postnatal day 30 and continued to increase during development. Subsequently, Cre protein distribution was assessed by crossing Lcn5-Cre transgenic mice into the mT/mG reporter line. As expected, the Cre recombinase activity was only found in principal cells of the middle/distal caput epididymis. The tissue-specific expression of Cre protein in the caput epididymis was further confirmed using Lcn5-Cre mice crossed with a mouse strain carrying Aip1 conditional alleles (Aip1(flox/+)). In summary, a transgenic mouse line expressing Cre recombinase in the principal cells of caput epididymis was established. This transgenic mouse line can be used to generate conditional, caput epididymis-specific knockout mouse models by crossing with mice harboring floxed (LoxP flanked) genes.
    Biology of Reproduction 01/2013; 88(3). DOI:10.1095/biolreprod.112.104034 · 3.45 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Epididymis plays a crucial role in regulating the development of sperm motility and fertilizing capacity. To study the function of genes in the caput epididymidis using the Cre/loxP system, we generated Lcn5-Cre transgenic mice in which the expression of Cre recombinase is driven by the 1.8-kb Lcn5 promoter. A total of 11 founder mice carrying the Lcn5-Cre transgene were identified by PCR from 38 offspring, and the integration efficiency was 28.9%. However, only 1 of the 11 transgenic mouse lines were revealed with the Cre recombinase expressed specifically in caput epididymidis. Furthermore, expression of Cre mRNA was first observed on Postnatal Day 30 and continued to increase during development. Subsequently, Cre protein distribution was assessed by crossing Lcn5-Cre trans-genic mice into the mT/mG reporter line. As expected, the Cre recombinase activity was only found in principal cells of the middle/distal caput epididymidis. The tissue-specific expression of Cre protein in the caput epididymidis was further confirmed using Lcn5-Cre mice crossed with a mouse strain carrying Aip1 conditional alleles (Aip1 flox/+). In summary, a transgenic mouse line expressing Cre recombinase in principal cells of caput epididymidis was established. This transgenic mouse line can be used to generate conditional, caput epididymidis-specific knock-out mouse models by crossing with mice harboring floxed (LoxP flanked) genes. caput, Cre recombinase, epididymis, Lcn5 promoter, male reproductive tract, transgenic/knockout model INTRODUCTION
Show more